CM
MGNX icon

Caption Management’s MacroGenics MGNX Stock Holding History

Caption Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$213K – 1474
2024
Q2 		$213K Buy
+50,000
New +$487K ﹤0.01% 947
2023
Q3 		– Sell
-27,900
Closed -$149K – 1422
2023
Q2 		$149K Hold
27,900
– – ﹤0.01% 958
2023
Q1 		$200K Hold
27,900
– – ﹤0.01% 919
2022
Q4 		$187K Buy
+27,900
New +$153K ﹤0.01% 1073
2021
Q3 		– Sell
-15,200
Closed -$408K – 1677
2021
Q2 		$408K Hold
15,200
– – 0.01% 1092
2021
Q1 		$484K Buy
+15,200
New +$369K 0.01% 813

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's MGNX Position: Q3 2024 in Review

Caption Management sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 34,400 shares — an estimated $146K sold.

Caption Management first reported a position in MGNX in Q1 2019 and held it in 10 quarters. The position peaked at $3.15M in Q1 2021. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Caption Management reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 34,400 MacroGenics shares in Q3 2024, an estimated $146K.
  • Caption Management first reported a position in MacroGenics in Q1 2019 and held it in 10 quarters.
  • Caption Management's MacroGenics position peaked at $3.15M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.